Postoophorectomy Estrogen Use and Breast Cancer Risk

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Obstetrics and Gynecology

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/AOG.0b013e31825a717bPMID 22914389PMCID PMC3427539
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changing concepts: Menopausal hormone therapy and breast cancer.

  2012cited by this paper
• Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.

  2012cited by this paper
• Trends in Bilateral Oophorectomy at the Time of Hysterectomy for Benign Disease

  2011cited by this paper
• Paradoxical Clinical Effect of Estrogen on Breast Cancer Risk: A “New” Biology of Estrogen-induced Apoptosis

  2011cited by this paper
• Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women's contraceptive and reproductive experiences study.

  2011cited by this paper
• Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT

  2011cited by this paper
• Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery?

  2011cited by this paper
• Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy

  2011cited by this paper
• Premature menopause or early menopause: long-term health consequences.

  2010cited by this paper
• Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study

  2010cited by this paper
• Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study.

  2009cited by this paper
• Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting

  2009cited by this paper
• Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study

  2009cited by this paper
• Menopausal Hormone Therapy and Breast Cancer Risk in the NIH-AARP Diet and Health Study Cohort

  2008cited by this paper
• Comparison of patient recall of hormone therapy with physician records

  2007cited by this paper
• Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

  2006cited by this paper
• Estrogen carcinogenesis in breast cancer.

  2006cited by this paper
• Unopposed estrogen therapy and the risk of invasive breast cancer.

  2006cited by this paper
• Familial relative risk estimates for use in epidemiologic analyses.

  2006cited by this paper
• Bilateral oophorectomy and premature menopause.

  2005cited by this paper
• Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

  2005cited by this paper
• Postmenopausal estrogen and progestin use in relation to breast cancer risk.

  2002cited by this paper
• Effect of Long-Term Estrogen Deprivation on Apoptotic Responses of Breast Cancer Cells to 17β-Estradiol

  2001cited by this paper
• Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol.

  2001cited by this paper
• Agreement of self-reported use of menopausal hormone replacement therapy with physician reports.

  1999cited by this paper
• The risk of breast cancer following reproductive surgery.

  1999cited by this paper
• Lactation in relation to postmenopausal breast cancer.

  1999cited by this paper
• Menstrual factors in relation to breast cancer risk.

  1998cited by this paper
• Hysterectomy, Oophorectomy in Premenopause, and Risk of Breast Cancer

  1997cited by this paper
• Breast cancer risk associated with gynecologic surgery and indications for such surgery

  1997cited by this paper
• Can we measure prior postmenopausal estrogen/progestin use? The Postmenopausal Estrogen/Progestin Interventions Trial. The PEPI Investigators.

  1997cited by this paper
• Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.

  1997cited by this paper
• Can We Measure Prior Postmenopausal Estrogen/Progestin Use? The Postmenopausal Estrogen/Progestin Interventions Trial

  1997cited by this paper
• The role of reproductive and menstrual factors in cancer of the breast before and after menopause.

  1996cited by this paper
• Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women.

  1995cited by this paper
• Consistency of perimenopausal estrogen use reporting by women in a population-based prospective study.

  1992cited by this paper
• Agreement between interview information and physician records on history of menopausal estrogen use.

  1990cited by this paper
• Menstrual factors and risk of breast cancer.

  1988cited by this paper
• Hysterectomy, tubal sterilization, and the risk of breast cancer.

  1988cited by this paper
• Reproducibility and validity of self-reported menopausal status in a prospective cohort study.

  1987cited by this paper

• Association between hysterectomy for benign indications and the risk of breast cancer: a systematic review and meta- analysis

  2025cites this paper
• Hysterectomy, bilateral oophorectomy, and breast cancer risk in a racially diverse prospective cohort study.

  2023cites this paper
• Revisión de los factores de riesgo y factores protectores para el cáncer de mama

  2022cites this paper
• Breast Cancer and Major Deviations of Genetic and Gender-related Structures and Function.

  2020cites this paper
• Yoga For Menopausal Symptoms: A Review

  2018cites this paper
• Hormone Therapy in Breast Cancer Survivors and Those at High Risk for Breast Cancer.

  2018cites this paper
• Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study

  2017cites this paper
• Controversies in the risk of neoplasia in GH deficiency.

  2017cites this paper
• Risk of colorectal cancer with hysterectomy and oophorectomy: A systematic review and meta-analysis.

  2016cites this paper
• Associations of Premenopausal Hysterectomy and Oophorectomy With Breast Cancer Among Black and White Women: The Carolina Breast Cancer Study, 1993-2001.

  2016cites this paper
• Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.

  2014cites this paper
• Bilateral oophorectomy and risk of cancer in African American women

  2014cites this paper
• Estrogen suppresses adipogenesis by inhibiting S100A16 expression

  2014cites this paper
• Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health

  2013cites this paper
• Post-oophorectomy estrogen use and breast cancer risk.

  2013cites this paper
• Climacteric Commentaries

  2012cites this paper